Pelvic lymph node dissection in prostate cancer: current evidence, controversies, and future directions
Key Points
The aim is to assess the role of pelvic lymph node dissection in the management of prostate cancer, focusing on current evidence and future implications.
Reviewed contemporary evidence on ePLND in the context of prostate cancer management.
Analyzed the impact of PSMA imaging on nodal staging and treatment outcomes.
ePLND shows promise in enhancing oncologic outcomes for selected prostate cancer patients.
Current evidence highlights ongoing controversies regarding the necessity and benefits of ePLND.
Abstract
In the contemporary PSMA imaging era, ePLND continues to play an important role in nodal staging and may contribute to improved oncologic outcomes in carefully selected patients.